Literature DB >> 29434828

Mitogen-activated protein kinase signaling pathway in oral cancer.

Qian Peng1, Zhiyuan Deng1, Hao Pan1, Liqun Gu1, Ousheng Liu1, Zhangui Tang1.   

Abstract

The mitogen-activated protein kinase (MAPK) signaling pathway is associated with tumor cell proliferation, differentiation, apoptosis, angiogenesis, invasion and metastasis. The present review assesses the involvement of the MAPK signaling pathway in oral cancer progression and invasion based on analysis of individual sub-pathways and their mechanisms of action. The regulation of this pathway for targeted oral cancer therapy is explored and the challenges confronting this, as well as corresponding potential solutions, are discussed. Exploring this pathway with an emphasis on its components, subfamilies, sub-pathways, interactions with other pathways and clinical practice modes may improve oral cancer treatment.

Entities:  

Keywords:  inhibitor; kinase; mitogen-activated protein kinase signaling pathway; oral cancer; oral squamous cell carcinoma; therapeutic targets; treatment

Year:  2017        PMID: 29434828      PMCID: PMC5776165          DOI: 10.3892/ol.2017.7491

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  76 in total

1.  Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition.

Authors:  Tamer A Ahmed; John Hayslip; Markos Leggas
Journal:  Leuk Res       Date:  2014-09-16       Impact factor: 3.156

2.  BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.

Authors:  Rachel N Grisham; Gopa Iyer; Karuna Garg; Deborah Delair; David M Hyman; Qin Zhou; Alexia Iasonos; Michael F Berger; Fanny Dao; David R Spriggs; Douglas A Levine; Carol Aghajanian; David B Solit
Journal:  Cancer       Date:  2012-08-28       Impact factor: 6.860

3.  Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway.

Authors:  Ren-Hong Huang; Ying-Jun Quan; Jin-Hong Chen; Ting-Feng Wang; Ming Xu; Min Ye; Hao Yuan; Chong-Jie Zhang; Xiao-Jian Liu; Zhi-Jun Min
Journal:  Cell Physiol Biochem       Date:  2017-04-03

4.  ras gene mutations in oral cancer in eastern India.

Authors:  N Das; J Majumder; U B DasGupta
Journal:  Oral Oncol       Date:  2000-01       Impact factor: 5.337

5.  Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.

Authors:  Mi Kyung Park; Hye Ja Lee; Jennifer Shin; Minsoo Noh; Soo Youl Kim; Chang Hoon Lee
Journal:  Biochim Biophys Acta       Date:  2011-07-26

6.  The ERK Cascade: Distinct Functions within Various Subcellular Organelles.

Authors:  Inbal Wortzel; Rony Seger
Journal:  Genes Cancer       Date:  2011-03

7.  Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer.

Authors:  K Kavitha; J Kowshik; T Kranthi Kiran Kishore; Abdul Basit Baba; S Nagini
Journal:  Biochim Biophys Acta       Date:  2013-05-29

8.  S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer.

Authors:  Feng-Yao Tang; En-Pei Isabel Chiang; Jing-Gung Chung; Hong-Zin Lee; Chia-Yun Hsu
Journal:  J Nutr Biochem       Date:  2009-01-20       Impact factor: 6.048

9.  Targeted deletion of the ERK5 MAP kinase impairs neuronal differentiation, migration, and survival during adult neurogenesis in the olfactory bulb.

Authors:  Tan Li; Yung-Wei Pan; Wenbin Wang; Glen Abel; Junhui Zou; Lihong Xu; Daniel R Storm; Zhengui Xia
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

10.  Cardiotoxin III inhibits proliferation and migration of oral cancer cells through MAPK and MMP signaling.

Authors:  Ching-Yu Yen; Shih-Shin Liang; Lo-Yi Han; Han-Lin Chou; Chon-Kit Chou; Shinne-Ren Lin; Chien-Chih Chiu
Journal:  ScientificWorldJournal       Date:  2013-04-08
View more
  26 in total

1.  Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.

Authors:  Senthilnath Lakshmanachetty; Velmurugan Balaiya; Whitney A High; Maranke I Koster
Journal:  Mol Cancer Res       Date:  2019-03-25       Impact factor: 5.852

Review 2.  Studying molecular signaling in major angiogenic diseases.

Authors:  Jhansi Nathan; Rabiathul Shameera; Gajalakshmi Palanivel
Journal:  Mol Cell Biochem       Date:  2022-05-18       Impact factor: 3.842

Review 3.  PD-1/PD-L1 pathway: current researches in cancer.

Authors:  Yanyan Han; Dandan Liu; Lianhong Li
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

4.  Low-intensity pulsed ultrasound suppresses proliferation and promotes apoptosis via p38 MAPK signaling in rat visceral preadipocytes.

Authors:  Tianhua Xu; Jia Gu; Chenghai Li; Xiasheng Guo; Juan Tu; Dong Zhang; Wei Sun; Xiangqing Kong
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

5.  Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma.

Authors:  Qiqi Wu; Ruoyan Cao; Juan Chen; Xiaoli Xie
Journal:  Exp Ther Med       Date:  2019-09-11       Impact factor: 2.447

Review 6.  Clinical update on head and neck cancer: molecular biology and ongoing challenges.

Authors:  Elham Alsahafi; Katheryn Begg; Ivano Amelio; Nina Raulf; Philippe Lucarelli; Thomas Sauter; Mahvash Tavassoli
Journal:  Cell Death Dis       Date:  2019-07-15       Impact factor: 8.469

7.  Low Concentration of Withaferin a Inhibits Oxidative Stress-Mediated Migration and Invasion in Oral Cancer Cells.

Authors:  Tzu-Jung Yu; Jen-Yang Tang; Fu Ou-Yang; Yen-Yun Wang; Shyng-Shiou F Yuan; Kevin Tseng; Li-Ching Lin; Hsueh-Wei Chang
Journal:  Biomolecules       Date:  2020-05-17

8.  Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.

Authors:  Kelly L Hamilton; Stephanie A Sheehan; Edward P Retzbach; Clinton A Timmerman; Garret B Gianneschi; Patrick J Tempera; Premalatha Balachandran; Gary S Goldberg
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-17       Impact factor: 4.553

9.  PlatyphyllenoneExerts Anti-Metastatic Effects on Human Oral Cancer Cells by Modulating Cathepsin L Expression, MAPK Pathway and Epithelial-Mesenchymal Transition.

Authors:  V Bharath Kumar; Jen-Tsun Lin; B Mahalakshmi; Yi-Ching Chuang; Hsin-Yu Ho; Chia-Chieh Lin; Yu-Sheng Lo; Ming-Ju Hsieh; Mu-Kuan Chen
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

10.  Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases.

Authors:  Marinela Bostan; Georgiana Gabriela Petrică-Matei; Gabriela Ion; Nicoleta Radu; Mirela Mihăilă; Răzvan Hainăroşie; Lorelei Irina Braşoveanu; Viviana Roman; Carolina Constantin; Monica Teodora Neagu
Journal:  Exp Ther Med       Date:  2019-10-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.